DPC4 (SMAD4) mediates transforming growth factor-beta 1 (TGF-beta 1) induced growth inhibition and transcriptional response in breast tumour cells

被引:134
作者
deWinter, JP
Roelen, BAJ
tenDijke, P
vanderBurg, B
vandenEijndenvanRaaij, A
机构
[1] NETHERLANDS INST DEV BIOL,HUBRECHT LAB,NL-3584 CT UTRECHT,NETHERLANDS
[2] LUDWIG INST CANC RES,S-75124 UPPSALA,SWEDEN
关键词
DPC4; Smad; TGF-beta; activin; tumour suppressor;
D O I
10.1038/sj.onc.1201017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A family of structurally related proteins homologous to the Drosophila mothers against dpp (MAD) gene product have been implicated in signal transduction by members of the TGF-beta superfamily, One of these MAD related proteins (DPC4) has been cloned as a candidate tumour suppressor in pancreas carcinomas, suggesting a role for DPC4 in growth regulation by TGF-beta related proteins, The involvement of DPC4 in TGF-beta 1 induced growth inhibition and transcriptional response is demonstrated here, by the introduction of DPC4 in the TGF-beta and activin insensitive breast tumour cell line MDA-MB-468, from which the DPC4 gene is deleted, Transfection of DPC4 in this cell line restores both growth inhibition and the induction of a TGF-beta sensitive reporter construct (3TPlux) by TGF-beta 1, In contrast, a DPC4 splice variant lacking amino acid residues 223-301 and cloned from another TGF-beta and activin resistant breast tumour cell line (MDA-MB-231), does not restore the induction of the 3TPlux reporter by TGF-beta 1, We also show that in this latter cell line activin resistance is partly due to the absence of a functional activin type IB receptor, These results indicate that DPC4 is part of the TGF-beta signalling cascade and mediates TGF-beta induced growth inhibition, Together with the deletion of DPC4 from pancreas carcinomas these results suggest a role for DPC4 as a tumour suppressor.
引用
收藏
页码:1891 / 1899
页数:9
相关论文
共 42 条
[1]  
Attisano L, 1996, MOL CELL BIOL, V16, P1066
[2]   A novel mesoderm inducer, Madr2 functions in the activin signal transduction pathway [J].
Baker, JC ;
Harland, RM .
GENES & DEVELOPMENT, 1996, 10 (15) :1880-1889
[3]   GENETIC ALTERATIONS IN BREAST-CANCER [J].
BIECHE, I ;
LIDEREAU, R .
GENES CHROMOSOMES & CANCER, 1995, 14 (04) :227-251
[4]   TYPE-I RECEPTORS SPECIFY GROWTH-INHIBITORY AND TRANSCRIPTIONAL RESPONSES TO TRANSFORMING GROWTH-FACTOR-BETA AND ACTIVIN [J].
CARCAMO, J ;
WEIS, FMB ;
VENTURA, F ;
WIESER, R ;
WRANA, JL ;
ATTISANO, L ;
MASSAGUE, J .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) :3810-3821
[5]   A transcriptional partner for MAD proteins in TGF-beta signalling [J].
Chen, X ;
Rubock, MJ ;
Whitman, M .
NATURE, 1996, 383 (6602) :691-696
[6]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[7]   Truncated activin type II receptors inhibit activin bioactivity by the formation of heteromeric complexes with activin type I receptors [J].
deWinter, JP ;
deVries, CJM ;
vanAchterberg, TAE ;
Ameerun, RF ;
Feijen, A ;
Sugino, H ;
deWaele, P ;
Huylebroeck, D ;
Verschueren, K ;
vandenEijndenvanRaaij, AJM .
EXPERIMENTAL CELL RESEARCH, 1996, 224 (02) :323-334
[8]   MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma [J].
Eppert, K ;
Scherer, SW ;
Ozcelik, H ;
Pirone, R ;
Hoodless, P ;
Kim, H ;
Tsui, LC ;
Bapat, B ;
Gallinger, S ;
Andrulis, IL ;
Thomsen, GH ;
Wrana, JL ;
Attisano, L .
CELL, 1996, 86 (04) :543-552
[9]   Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily [J].
Graff, JM ;
Bansal, A ;
Melton, DA .
CELL, 1996, 85 (04) :479-487
[10]  
Gucev ZS, 1996, CANCER RES, V56, P1545